Note: Ingredients listed on restricted chemical lists
EC/CAS
200-334-9/57-50-1
Name of the chemical
Sucrose, pure C12H22O11
Concentration
39% <60% <5%
General Information
Revision date
2015-12-18
Product name
EMPLICITI (elotuzumab) for injection
Product Synonyms
Empliciti (elotuzumab)300 mg/vial and 400 mg/vial, Elotuzumab Lyophilized powder
CAS No.
57-50-1
1.2.1 Relevant identified uses
This material is a finished drug product for patient use. It is used in the treatment of cancer. It is a protein
Emergency telephone
USA (also Canada, Puerto Rico and the
Icons in SDS
Company Information
company name
usa and puerto rico
e-mail address of the competent person responsible for the Safety Data Sheet
MG-GBS-MSDS-Request@bms.com
GHS Information
Signal word
Danger
Section 2
SECTION 2: Hazards identification
Classification and Labelling Common to All Jurisdictions
2.1 Classification of the substance or mixture
Respiratory Sensitization - Category 1B Specific Target Organ Systemic Toxicity (Repeated Exposure) - Category 1 Substance not fully tested.
Signal word
Danger
Hazard statements
May cause allergy or asthma symptoms or breathing difficulties if inhaled. Causes damage to organs (immune system, teeth) through prolonged or repeated exposure.
Precautionary statements
Do not breathe dust. In case of insufficient ventilation, wear suitable respiratory equipment. Wash thoroughly after handling. Do not eat, drink or smoke when using this product.
